Literature DB >> 19481311

Meningococcal interactions with the host.

Etienne Carbonnelle1, Darryl J Hill, Philippe Morand, Natalie J Griffiths, Sandrine Bourdoulous, Isabel Murillo, Xavier Nassif, Mumtaz Virji.   

Abstract

Neisseria meningitidis interacts with host tissues through hierarchical, concerted and co-ordinated actions of a number of adhesins; many of which undergo antigenic and phase variation, a strategy that helps immune evasion. Three major structures, pili, Opa and Opc predominantly influence bacterial adhesion to host cells. Pili and Opa proteins also determine host and tissue specificity while Opa and Opc facilitate efficient cellular invasion. Recent studies have also implied a role of certain adhesin-receptor pairs in determining increased host susceptibility to infection. This chapter examines our current knowledge of meningococcal adhesion and invasion mechanisms particularly related to human epithelial and endothelial cells which are of primary importance in the disease process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481311     DOI: 10.1016/j.vaccine.2009.04.069

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  50 in total

1.  The meningococcal minor pilin PilX is responsible for type IV pilus conformational changes associated with signaling to endothelial cells.

Authors:  Terry Brissac; Guillain Mikaty; Guillaume Duménil; Mathieu Coureuil; Xavier Nassif
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 2.  Biofilm formation by the human pathogen Neisseria meningitidis.

Authors:  Martin Lappann; Ulrich Vogel
Journal:  Med Microbiol Immunol       Date:  2010-04-08       Impact factor: 3.402

3.  Inhibitors of the Neisseria meningitidis PilF ATPase provoke type IV pilus disassembly.

Authors:  Flore Aubey; Jean-Philippe Corre; Youxin Kong; Ximing Xu; Dorian Obino; Sylvie Goussard; Catherine Lapeyrere; Judith Souphron; Cedric Couturier; Stéphane Renard; Guillaume Duménil
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-04       Impact factor: 11.205

Review 4.  Type IV pilin proteins: versatile molecular modules.

Authors:  Carmen L Giltner; Ylan Nguyen; Lori L Burrows
Journal:  Microbiol Mol Biol Rev       Date:  2012-12       Impact factor: 11.056

5.  Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence.

Authors:  Biju Joseph; Susanne Schneiker-Bekel; Anja Schramm-Glück; Jochen Blom; Heike Claus; Burkhard Linke; Roland F Schwarz; Anke Becker; Alexander Goesmann; Matthias Frosch; Christoph Schoen
Journal:  J Bacteriol       Date:  2010-08-13       Impact factor: 3.490

6.  Neisseria meningitidis Opc invasin binds to the sulphated tyrosines of activated vitronectin to attach to and invade human brain endothelial cells.

Authors:  Claudia Sa E Cunha; Natalie J Griffiths; Mumtaz Virji
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

Review 7.  Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease.

Authors:  Darryl J Hill; Natalie J Griffiths; Elena Borodina; Mumtaz Virji
Journal:  Clin Sci (Lond)       Date:  2010-02-09       Impact factor: 6.124

8.  Meningococcal PilV potentiates Neisseria meningitidis type IV pilus-mediated internalization into human endothelial and epithelial cells.

Authors:  Hideyuki Takahashi; Tatsuo Yanagisawa; Kwang Sik Kim; Shigeyuki Yokoyama; Makoto Ohnishi
Journal:  Infect Immun       Date:  2012-09-17       Impact factor: 3.441

9.  Understanding Mycobacterium avium subspecies hominissuis microaggregate mediated pathogenesis.

Authors:  Fernando Lopes Leivas Leite
Journal:  Virulence       Date:  2015       Impact factor: 5.882

10.  Transcriptional profiling of Neisseria meningitidis interacting with human epithelial cells in a long-term in vitro colonization model.

Authors:  Ariann Hey; Ming-Shi Li; Michael J Hudson; Paul R Langford; J Simon Kroll
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.